Elevance Health Inc. closed 27.50% below its 52-week high of $567.26, which the company achieved on September 3rd.

Health-care companies rose sharply amid strong earnings. Elevance Health, the health insurer formerly known as Anthem, posted fourth-quarter profit and revenue ahead of Wall Street targets ...

Elevance Health Inc. closed $174.10 below its 52-week high ($567.26), which the company achieved on September 3rd.

Analyst David Windley from Jefferies maintained a Buy rating on Elevance Health (ELV – Research Report) and increased the price target to ...

Whit Mayo, an analyst from Leerink Partners, reiterated the Buy rating on Elevance Health (ELV – Research Report). The associated price target ...

The stock has lagged behind the Dow over the longer term as well. ELV stock has declined 16.7% on a YTD basis and 18.5% over the past 52 weeks compared to DOWI’s 18.8% gains in 2024 and 23.9% ...

Elevance Health's board has raised the health insurer and healthcare-services provider's quarterly dividend by 4.9%, to $1.71 from $1.63. The new payout, equal to $6.84 a year, represents an ...

The Dow Jones Industrial Average (DJIA) is slipping today despite investors preparing for the upcoming Federal Reserve meeting. Traders have been waiting for this meeting as it will be a major ...

The Dow Jones Industrial ... are hobbling the average’s overall performance. UnitedHealth Group (UNH) tumbled 4.5%, falling below $520 per share after the major health sector player missed ...